Erratum: ITRAQ-based Quantitative Protein Expression Profiling and MRM Verification of Markers in Type 2 Diabetes (Journal of Proteome Research (2012) 11 (5527-5537) DOI: 10.1021/pr300798z);ITRAQ-based quantitative protein expression profiling and MRM verification of markers in type 2 diabetes

Journal of Proteome Research

Volumn 11, Issue 11, 2012, Pages 5527-5539

  Kaur, Prabhjit ^a   Rizk, Nasser M ^b   Ibrahim, Sereen ^b   Younes, Noura ^c   Uppal, Arushi ^a   Dennis, Kevin ^a   Karve, Tejaswita ^a   Blakeslee, Kenneth ^d   Kwagyan, John ^e   Zirie, Mahmoud ^c   Ressom, Habtom W ^a   Cheema, Amrita K ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b QATAR UNIVERSITY   (Qatar)

^c HAMAD MEDICAL CORPORATION   (Qatar)

^d WATERS CORPORATION   (United States)

^e HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Biomarkers; Diabetes; metabolic syndrome; MRM; Proteomics

Indexed keywords

EID: 84868329009     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr4000224     Document Type: Erratum

References (75)

1. Gjesing, A. P.; Pedersen, O. 'Omics'-driven discoveries in prevention and treatment of type 2 diabetes Eur. J. Clin. Invest. 2012, 42 (6) 579-88
2. Seshasai, S. R.; Kaptoge, S.; Thompson, A.; Di Angelantonio, E.; Gao, P.; Sarwar, N.; Whincup, P. H.; Mukamal, K. J.; Gillum, R. F.; Holme, I.; Njolstad, I.; Fletcher, A.; Nilsson, P.; Lewington, S.; Collins, R.; Gudnason, V.; Thompson, S. G.; Sattar, N.; Selvin, E.; Hu, F. B.; Danesh, J. Diabetes mellitus, fasting glucose, and risk of cause-specific death N. Engl. J. Med. 2011, 364 (9) 829-41
3. Kolberg, J. A.; Jorgensen, T.; Gerwien, R. W.; Hamren, S.; McKenna, M. P.; Moler, E.; Rowe, M. W.; Urdea, M. S.; Xu, X. M.; Hansen, T.; Pedersen, O.; Borch-Johnsen, K. Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort Diabetes Care 2009, 32 (7) 1207-12
4. Tuomilehto, J.; Lindstrom, J.; Eriksson, J. G.; Valle, T. T.; Hamalainen, H.; Ilanne-Parikka, P.; Keinanen-Kiukaanniemi, S.; Laakso, M.; Louheranta, A.; Rastas, M.; Salminen, V.; Uusitupa, M. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance N. Engl. J. Med. 2001, 344 (18) 1343-50
5. Abdul-Ghani, M. A.; Williams, K.; DeFronzo, R. A.; Stern, M. What is the best predictor of future type 2 diabetes? Diabetes Care 2007, 30 (6) 1544-8
6. Wilson, P. W.; Meigs, J. B.; Sullivan, L.; Fox, C. S.; Nathan, D. M.; D'Agostino, R. B., Sr. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study Arch. Intern. Med. 2007, 167 (10) 1068-74
7. Lapolla, A.; Porcu, S.; Traldi, P. Some views on proteomics in diabetes Clin. Chem. Lab. Med. 2011, 49 (6) 943-57
8. Sundsten, T.; Ortsater, H. Proteomics in diabetes research Mol. Cell. Endocrinol. 2009, 297 (1-2) 93-103
9. Herder, C.; Karakas, M.; Koenig, W. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease Clin. Pharmacol. Ther. 2011, 90 (1) 52-66
10. Nakatani, S.; Kakehashi, A.; Ishimura, E.; Yamano, S.; Mori, K.; Wei, M.; Inaba, M.; Wanibuchi, H. Targeted proteomics of isolated glomeruli from the kidneys of diabetic rats: sorbin and SH3 domain containing. 2. is a novel protein associated with diabetic nephropathy Exp. Diabetes Res. 2011, 2011, 979354
11. Mullen, W.; Delles, C.; Mischak, H. Urinary proteomics in the assessment of chronic kidney disease Curr. Opin. Nephrol. Hypertens. 2011, 20 (6) 654-61
12. Prunotto, M.; Ghiggeri, G.; Bruschi, M.; Gabbiani, G.; Lescuyer, P.; Hocher, B.; Chaykovska, L.; Berrera, M.; Moll, S. Renal fibrosis and proteomics: current knowledge and still key open questions for proteomic investigation J. Proteomics 2011, 74 (10) 1855-70
13. Kim, H. J.; Kim, P. K.; Yoo, H. S.; Kim, C. W. Comparison of tear proteins between healthy and early diabetic retinopathy patients Clin. Biochem. 2012, 45 (1-2) 60-7
14. Merchant, M. L.; Klein, J. B. Proteomic discovery of diabetic nephropathy biomarkers Adv. Chronic Kidney Dis. 2010, 17 (6) 480-6
15. VanGuilder, H. D.; Bixler, G. V.; Kutzler, L.; Brucklacher, R. M.; Bronson, S. K.; Kimball, S. R.; Freeman, W. M. Multi-modal proteomic analysis of retinal protein expression alterations in a rat model of diabetic retinopathy PLoS One 2011, 6 (1) e16271
16. Kim, K.; Kim, S. J.; Yu, H. G.; Yu, J.; Park, K. S.; Jang, I. J.; Kim, Y. Verification of biomarkers for diabetic retinopathy by multiple reaction monitoring J. Proteome Res. 2010, 9 (2) 689-99
17. Collins, H. W.; Buettger, C.; Matschinsky, F. High-resolution two-dimensional polyacrylamide gel electrophoresis reveals a glucose-response protein of 65 kDa in pancreatic islet cells Proc. Natl. Acad. Sci. U.S.A. 1990, 87 (14) 5494-8
18. Collins, H.; Najafi, H.; Buettger, C.; Rombeau, J.; Settle, R. G.; Matschinsky, F. M. Identification of glucose response proteins in two biological models of beta-cell adaptation to chronic high glucose exposure J. Biol. Chem. 1992, 267 (2) 1357-66
19. Fernandez, C.; Fransson, U.; Hallgard, E.; Spegel, P.; Holm, C.; Krogh, M.; Warell, K.; James, P.; Mulder, H. Metabolomic and proteomic analysis of a clonal insulin-producing beta-cell line (INS-1 832/13) J. Proteome Res. 2008, 7 (1) 400-11
20. Zhang, R.; Barker, L.; Pinchev, D.; Marshall, J.; Rasamoelisolo, M.; Smith, C.; Kupchak, P.; Kireeva, I.; Ingratta, L.; Jackowski, G. Mining biomarkers in human sera using proteomic tools Proteomics 2004, 4 (1) 244-56
21. Tsuneki, H.; Ishizuka, M.; Terasawa, M.; Wu, J.-B.; Sasaoka, T.; Kimura, O. Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans BMC Pharmacol. 2004, 4, 8
22. Kiga, C.; Nakagawa, T.; Koizumi, K.; Sakurai, H.; Shibagaki, Y.; Ogawa, K.; Goto, H.; Saiki, I. Expression patterns of plasma proteins in spontaneously diabetic rats after oral administration of a Kampo medicine, Hachimi-jio-gan, using SELDI ProteinChip platform Biol. Pharm. Bull. 2005, 28 (6) 1031-7
23. Jiang, M.; Jia, L.; Jiang, W.; Hu, X.; Zhou, H.; Gao, X.; Lu, Z.; Zhang, Z. Protein disregulation in red blood cell membranes of type 2 diabetic patients Biochem. Biophys. Res. Commun. 2003, 309 (1) 196-200
24. Friedewald, W. T.; Levy, R. I.; Fredrickson, D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin. Chem. 1972, 18 (6) 499-502
25. Cham, B. E.; Knowles, B. R. A solvent system for delipidation of plasma or serum without protein precipitation J. Lipid Res. 1976, 17 (2) 176-81
26. Tirumalai, R. S.; Chan, K. C.; Prieto, D. A.; Issaq, H. J.; Conrads, T. P.; Veenstra, T. D. Characterization of the low molecular weight human serum proteome Mol. Cell. Proteomics 2003, 2 (10) 1096-103
27. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 1976, 72, 248-54
28. Karp, N. A.; Lilley, K. S. Investigating sample pooling strategies for DIGE experiments to address biological variability Proteomics 2009, 9 (2) 388-97
29. Weinkauf, M.; Hiddemann, W.; Dreyling, M. Sample pooling in 2-D gel electrophoresis: a new approach to reduce nonspecific expression background Electrophoresis 2006, 27 (22) 4555-8
30. Apweiler, R.; Bairoch, A.; Wu, C. H.; Barker, W. C.; Boeckmann, B.; Ferro, S.; Gasteiger, E.; Huang, H.; Lopez, R.; Magrane, M.; Martin, M. J.; Natale, D. A.; O'Donovan, C.; Redaschi, N.; Yeh, L. S. UniProt: the Universal Protein knowledgebase Nucleic Acids Res. 2004, 32 (Database issue) D115-9
31. Weyer, C.; Hanson, R. L.; Tataranni, P. A.; Bogardus, C.; Pratley, R. E. A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia Diabetes 2000, 49 (12) 2094-101
32. Escoffier, P.; Paris, L.; Bodaghi, B.; Danis, M.; Mazier, D.; Marinach-Patrice, C. Pooling aqueous humor samples: bias in 2D-LC-MS/MS strategy? J. Proteome Res. 2010, 9 (2) 789-97
33. Sundsten, T.; Ostenson, C. G.; Bergsten, P. Serum protein patterns in newly diagnosed type 2 diabetes mellitus-influence of diabetic environment and family history of diabetes Diabetes Metab. Res. Rev. 2008, 24 (2) 148-54
34. Burk, R. F.; Hill, K. E.; Selenoprotein, P. An extracellular protein with unique physical characteristics and a role in selenium homeostasis Annu. Rev. Nutr. 2005, 25, 215-35
35. Misu, H.; Ishikura, K.; Kurita, S.; Takeshita, Y.; Ota, T.; Saito, Y.; Takahashi, K.; Kaneko, S.; Takamura, T. Inverse correlation between serum levels of selenoprotein P and adiponectin in patients with type 2 diabetes PLoS One 2012, 7 (4) e34952
36. Speckmann, B.; Sies, H.; Steinbrenner, H. Attenuation of hepatic expression and secretion of selenoprotein P by metformin Biochem. Biophys. Res. Commun. 2009, 387 (1) 158-63
37. Roman, M.; Lapolla, A.; Jitaru, P.; Sechi, A.; Cosma, C.; Cozzi, G.; Cescon, P.; Barbante, C. Plasma selenoproteins concentrations in type 2 diabetes mellitus-a pilot study Transl. Res 2010, 156 (4) 242-50
38. Yang, S. J.; Hwang, S. Y.; Choi, H. Y.; Yoo, H. J.; Seo, J. A.; Kim, S. G.; Kim, N. H.; Baik, S. H.; Choi, D. S.; Choi, K. M. Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis J. Clin. Endocrinol. Metab. 2011, 96 (8) E1325-9
39. Maritim, A. C.; Sanders, R. A.; Watkins, J. B., 3rd. Diabetes, oxidative stress, and antioxidants: a review J. Biochem. Mol. Toxicol. 2003, 17 (1) 24-38
40. Drews, G.; Krippeit-Drews, P.; Dufer, M. Oxidative stress and beta-cell dysfunction Pflugers Arch. 2010, 460 (4) 703-18
41. Lehtinen, A. B.; Burdon, K. P.; Lewis, J. P.; Langefeld, C. D.; Ziegler, J. T.; Rich, S. S.; Register, T. C.; Carr, J. J.; Freedman, B. I.; Bowden, D. W. Association of alpha-2-Heremans-Schmid glycoprotein polymorphisms with subclinical atherosclerosis J. Clin. Endocrinol. Metab. 2007, 92 (1) 345-52
42. Kodama, K.; Horikoshi, M.; Toda, K.; Yamada, S.; Hara, K.; Irie, J.; Sirota, M.; Morgan, A. A.; Chen, R.; Ohtsu, H.; Maeda, S.; Kadowaki, T.; Butte, A. J. Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes Proc. Natl. Acad. Sci. U.S.A. 2012, 109 (18) 7049-54
43. Bajorath, J.; Greenfield, B.; Munro, S. B.; Day, A. J.; Aruffo, A. Identification of CD44 residues important for hyaluronan binding and delineation of the binding site J. Biol. Chem. 1998, 273 (1) 338-43
44. Savu, O.; Ionescu-Tirgoviste, C.; Atanasiu, V.; Gaman, L.; Papacocea, R.; Stoian, I. Increase in total antioxidant capacity of plasma despite high levels of oxidative stress in uncomplicated type 2 diabetes mellitus J. Int. Med. Res. 2012, 40 (2) 709-16
45. Kwaan, H. C. Changes in blood coagulation, platelet function, and plasminogen-plasmin system in diabetes Diabetes 1992, 41 (Suppl 2) 32-5
46. Piazza, G.; Goldhaber, S. Z.; Kroll, A.; Goldberg, R. J.; Emery, C.; Spencer, F. A. Venous thromboembolism in patients with diabetes mellitus Am. J. Med. 2012, 125 (7) 709-16
47. Liu, W.; Lan, T.; Xie, X.; Huang, K.; Peng, J.; Huang, J.; Shen, X.; Liu, P.; Huang, H. S1P2 receptor mediates sphingosine-1-phosphate-induced fibronectin expression via MAPK signaling pathway in mesangial cells under high glucose condition Exp. Cell Res. 2012, 318 (8) 936-43
48. Takiishi, T.; Gysemans, C.; Bouillon, R.; Mathieu, C. Vitamin D and diabetes Endocrinol. Metab. Clin. North Am. 2010, 39 (2) 419-46 table of contents
49. Ando, Y. Transthyretin: it's miracle function and pathogenesis Rinsho Byori 2009, 57 (3) 228-35
50. Buxbaum, J. N.; Reixach, N. Transthyretin: the servant of many masters Cell. Mol. Life Sci. 2009, 66 (19) 3095-101
51. Hermo, R.; Mier, C.; Mazzotta, M.; Tsuji, M.; Kimura, S.; Gugliucci, A. Circulating levels of nitrated apolipoprotein A-I are increased in type 2 diabetic patients Clin. Chem. Lab. Med. 2005, 43 (6) 601-6
52. Speeckaert, M.; Huang, G.; Delanghe, J. R.; Taes, Y. E. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism Clin. Chim. Acta 2006, 372 (1-2) 33-42
53. Chaudhary, R.; Likidlilid, A.; Peerapatdit, T.; Tresukosol, D.; Srisuma, S.; Ratanamaneechat, S.; Sriratanasathavorn, C. Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease Cardiovasc. Diabetol. 2012, 11, 36
54. Chapman, M. J. Pitavastatin: novel effects on lipid parameters Atheroscler. Suppl. 2011, 12 (3) 277-84
55. Cangemi, C.; Skov, V.; Poulsen, M. K.; Funder, J.; Twal, W. O.; Gall, M. A.; Hjortdal, V.; Jespersen, M. L.; Kruse, T. A.; Aagard, J.; Parving, H. H.; Knudsen, S.; Hoilund-Carlsen, P. F.; Rossing, P.; Henriksen, J. E.; Argraves, W. S.; Rasmussen, L. M. Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetes Clin. Chem. 2011, 57 (11) 1556-65
56. Garcia-Pavia, P.; Avellana, P.; Bornstein, B.; Heine-Suner, D.; Cobo-Marcos, M.; Gomez-Bueno, M.; Segovia, J.; Alonso-Pulpon, L. A. Familial approach in hereditary transthyretin cardiac amyloidosis Rev. Esp. Cardiol. 2011, 64 (6) 523-6
57. Gouni-Berthold, I.; Krone, W.; Berthold, H. K. Vitamin D and cardiovascular disease Curr. Vasc. Pharmacol. 2009, 7 (3) 414-22
58. Li, R.; Nicklas, B.; Pahor, M.; Newman, A.; Sutton-Tyrrell, K.; Harris, T.; Lakatta, E.; Bauer, D. C.; Ding, J.; Satterfield, S.; Kritchevsky, S. B. Polymorphisms of angiotensinogen and angiotensin-converting enzyme associated with lower extremity arterial disease in the Health, Aging and Body Composition study J. Human Hypertens. 2007, 21 (8) 673-82
59. Thingholm, T. E.; Bak, S.; Beck-Nielsen, H.; Jensen, O. N.; Gaster, M. Characterization of human myotubes from type 2 diabetic and nondiabetic subjects using complementary quantitative mass spectrometric methods Mol. Cell. Proteomics 2011, 10 (9) M110 006650
60. Negri, A. L. Proximal tubule endocytic apparatus as the specific renal uptake mechanism for vitamin D-binding protein/25-(OH)D3 complex Nephrology (Carlton) 2006, 11 (6) 510-5
61. Thrailkill, K. M.; Nimmo, T.; Bunn, R. C.; Cockrell, G. E.; Moreau, C. S.; Mackintosh, S.; Edmondson, R. D.; Fowlkes, J. L. Microalbuminuria in type 1 diabetes is associated with enhanced excretion of the endocytic multiligand receptors megalin and cubilin Diabetes Care 2009, 32 (7) 1266-8
62. Marckmann, P.; Agerskov, H.; Thineshkumar, S.; Bladbjerg, E. M.; Sidelmann, J. J.; Jespersen, J.; Nybo, M.; Rasmussen, L. M.; Hansen, D.; Scholze, A. Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D Nephrol. Dial. Transplant. 2012, 27 (9) 3523-31
63. Chailurkit, L. O.; Aekplakorn, W.; Ongphiphadhanakul, B. The association between vitamin D status and type 2 diabetes in a Thai population, a cross-sectional study Clin. Endocrinol (Oxford) 2012, 77 (5) 658-64
64. Forouhi, N. G.; Ye, Z.; Rickard, A. P.; Khaw, K. T.; Luben, R.; Langenberg, C.; Wareham, N. J. Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies Diabetologia 2012, 55 (8) 2173-82
65. Makariou, S.; Liberopoulos, E.; Florentin, M.; Lagos, K.; Gazi, I.; Challa, A.; Elisaf, M. The relationship of vitamin D with non-traditional risk factors for cardiovascular disease in subjects with metabolic syndrome Arch. Med. Sci. 2012, 8 (3) 437-43
66. Kloting, N.; Graham, T. E.; Berndt, J.; Kralisch, S.; Kovacs, P.; Wason, C. J.; Fasshauer, M.; Schon, M. R.; Stumvoll, M.; Bluher, M.; Kahn, B. B. Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass Cell. Metab. 2007, 6 (1) 79-87
67. Fernandez-Real, J. M.; Moreno, J. M.; Ricart, W. Circulating retinol-binding protein-4 concentration might reflect insulin resistance-associated iron overload Diabetes 2008, 57 (7) 1918-25
68. Raila, J.; Henze, A.; Spranger, J.; Mohlig, M.; Pfeiffer, A. F.; Schweigert, F. J. Microalbuminuria is a major determinant of elevated plasma retinol-binding protein 4 in type 2 diabetic patients Kidney Int. 2007, 72 (4) 505-11
69. Akbay, E.; Muslu, N.; Nayir, E.; Ozhan, O.; Kiykim, A. Serum retinol binding protein 4 level is related with renal functions in Type 2 diabetes J. Endocrinol. Invest. 2010, 33 (10) 725-9
70. Motani, A.; Wang, Z.; Conn, M.; Siegler, K.; Zhang, Y.; Liu, Q.; Johnstone, S.; Xu, H.; Thibault, S.; Wang, Y.; Fan, P.; Connors, R.; Le, H.; Xu, G.; Walker, N.; Shan, B.; Coward, P. Identification and characterization of a non-retinoid ligand for retinol-binding protein 4 which lowers serum retinol-binding protein 4 levels in vivo J. Biol. Chem. 2009, 284 (12) 7673-80
71. Mody, N.; Graham, T. E.; Tsuji, Y.; Yang, Q.; Kahn, B. B. Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice Am. J. Physiol. Endocrinol. Metab. 2008, 294 (4) E785-93
72. Khan, S. R. Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome? Urol. Res. 2012, 40 (2) 95-112
73. Athyros, V. G.; Elisaf, M. S.; Alexandrides, T.; Achimastos, A.; Ganotakis, E.; Bilianou, E.; Karagiannis, A.; Liberopoulos, E. N.; Tziomalos, K.; Mikhailidis, D. P. Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis Angiology 2012, 63 (5) 358-66
74. Tian, J.; Wen, Y.; Yan, L.; Cheng, H.; Yang, H.; Wang, J.; Kozman, H.; Villarreal, D.; Liu, K. Vascular endothelial dysfunction in patients with newly diagnosed type 2 diabetes and effects of 2-year and 5-year multifactorial intervention Echocardiography 2011, 28 (10) 1133-40
75. Hood, L.; Flores, M. A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory N. Biotechnol. 2012, 29 (6) 613-24